Transfusion Medicine and Molecular Genetic Methods

Area of Science:

• Immunogenetics
• Transfusion Medicine
• Transplantation Immunology

Background:

• Blood transfusions and organ transplants require genetic compatibility between donors and recipients.
• Major blood groups (ABO, Rhesus) and other antigens (Kell, Kidd, Duffy, MNS, HPA, HLA) are critical for successful outcomes.
• High polymorphism of these antigens complicates donor selection, especially for multitransfused or immunized patients.

Purpose of the Study:

• To provide physicians with an accessible guide to transfusion and transplant antigen systems.
• To introduce novel molecular screening methods for blood group and tissue identity antigens.
• To highlight the importance of a comprehensive registry for efficient and safe donor-recipient matching.

Main Methods:

• Review of current literature on blood group antigen systems and their clinical significance.
• Discussion of molecular screening technologies for identifying antigen profiles.
• Explanation of the biological basis underlying these testing methods.

Main Results:

• Genetic mismatching is a primary complication in transfusion and transplantation.
• Polymorphic antigens (ABO, Rhesus, Kell, Kidd, Duffy, MNS, HPA, HLA) present significant challenges for donor matching.
• Molecular screening offers advanced methods for precise antigen typing.

Conclusions:

• A unified registry for transfusion and transplantation antigens is crucial for efficient blood and organ/stem cell sourcing.
• Understanding antigen biology and utilizing molecular screening can enhance transfusion safety and transplant success.
• Physicians need updated knowledge on these systems to manage transfusion-dependent patients effectively.